India's national regulatory authority, the Central Drugs Standard Control Organization, granted emergency use authorization for the ZyCoV-D DNA COVID-19 vaccine, manufactured by Zydus Cadila Healthcare, in individuals aged 12 years and older, using a three-dose intradermal immunization schedule. This is the first DNA COVID-19 vaccine to be authorized for emergency use.

Source: Over 25000 people impacting lives across 4 continents. Zydus Cadila

  • Share: